A pan-cancer and single-cell sequencing analysis of CD161, a promising onco-immunological biomarker in tumor microenvironment and immunotherapy

A pan-cancer and single-cell sequencing analysis of CD161, a promising onco-immunological biomarker in tumor microenvironment and immunotherapy

BackgroundCD161 has been linked to the appearance and development of various cancers.MethodsThe mutation map and the variation of CNVs and SNVs of CD161 were displayed according to cBioportal and GSCALite. We also evaluated the pathway enrichment and drug sensitivity of CD161 according to GSCALite....

Full description

Bibliographic Details
Main Authors: He Li, Ke Zhou, Kaiyue Wang, Hui Cao, Wantao Wu, Zeyu Wang, Ziyu Dai, Shi Chen, Yun Peng, Gelei Xiao, Peng Luo, Jian Zhang, Zaoqu Liu, Quan Cheng, Hao Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-12-01
Series:Frontiers in Immunology
Subjects:
CD161
prognosis
pan-cancer
mutation
macrophages
T cells
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.1040289/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.1040289/full

Similar Items